ABSTRACT NUMBER: ESOC2026LB148 LB148 - TENECTEPLASE FOR MEDIUM VESSEL OCCLUSION AT 4.5 TO 24 HOURS AFTER ISCHEMIC STROKE-SECONDARY ANALYSIS OF THE OPTION RANDOMIZED CLINICAL TRIAL
Ran Mo, Yingting Zuo, Gaoting MA, Junwei Hao · 2026
Read ABSTRACT NUMBER: ESOC2026LB148 LB148 - TENECTEPLASE FOR MEDIUM VESSEL OCCLUSION AT 4.5 TO 24 HOURS AFTER ISCHEMIC STROKE-SECONDARY ANALYSIS OF THE OPTION RANDOMIZED CLINICAL TRIAL by Ran Mo, Yingting Zuo, Gaoting MA, Junwei Hao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13144800.txt.
Description
Ran Mo, Junwei Hao and their co-authors report a secondary analysis of a trial of tenecteplase for stroke from medium vessel blockage, listed for 2026. Vessel-opening procedures have not helped these patients, and whether a clot drug given late can help was unclear.
The parent trial enrolled patients with salvageable tissue many hours after onset and compared the drug with standard care. In this analysis, most patients met medium vessel criteria, and they had larger early damage than other patients. Excellent recovery at ninety days was more common with the drug in both vessel groups. The authors call late tenecteplase a feasible option here.
Catalog record
| CREATOR | Ran Mo, Yingting Zuo, Gaoting MA, Junwei Hao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |